These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778 [TBL] [Abstract][Full Text] [Related]
3. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Mueller EW; Boucher BA Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611 [TBL] [Abstract][Full Text] [Related]
4. Comments to consensus document. Once-daily dosing of aminoglycosides from N. Anaizi. A supplement to dosage and monitoring in critically ill patients. Reimann IR; Meier-Hellmann A; Reinhart K; Hoffmann A Int J Clin Pharmacol Ther; 1997 Sep; 35(9):397. PubMed ID: 9314094 [No Abstract] [Full Text] [Related]
5. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
6. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis. Prescott WA; Nagel JL Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477 [TBL] [Abstract][Full Text] [Related]
7. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Vilay AM; Grio M; Depestel DD; Sowinski KM; Gao L; Heung M; Salama NN; Mueller BA Crit Care Med; 2011 Jan; 39(1):19-25. PubMed ID: 20890189 [TBL] [Abstract][Full Text] [Related]
8. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
9. Comment: a practical alternative to conventional aminoglycoside dosing. Lackner TE; Weiss P Ann Pharmacother; 1994 Jun; 28(6):809-10. PubMed ID: 7919581 [No Abstract] [Full Text] [Related]
10. Aminoglycoside dosing considerations in intensive care unit patients. Watling SM; Dasta JF Ann Pharmacother; 1993 Mar; 27(3):351-7. PubMed ID: 8267695 [TBL] [Abstract][Full Text] [Related]
11. Once-daily dosing of aminoglycoside antibiotics. Fisman DN; Kaye KM Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267 [TBL] [Abstract][Full Text] [Related]
12. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study]. Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218 [TBL] [Abstract][Full Text] [Related]
14. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment. Miyagawa CI New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400 [TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy. Periti P J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543 [TBL] [Abstract][Full Text] [Related]
16. Initial dosing of vancomycin in critically ill patients. Kees MG; Vögeler S; Hilpert JW Int J Antimicrob Agents; 2011 Jul; 38(1):91-2. PubMed ID: 21546217 [No Abstract] [Full Text] [Related]
17. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients. Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363 [TBL] [Abstract][Full Text] [Related]
18. What is new in the use of aminoglycosides in critically ill patients? Matthaiou DK; De Waele J; Dimopoulos G Intensive Care Med; 2014 Oct; 40(10):1553-5. PubMed ID: 24993463 [No Abstract] [Full Text] [Related]
19. First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients. Blackburn LM; Tverdek FP; Hernandez M; Bruno JJ Int J Antimicrob Agents; 2015 Jan; 45(1):46-53. PubMed ID: 25455848 [TBL] [Abstract][Full Text] [Related]
20. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Roberts JA; Lipman J Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]